A case of metachronous triple primary carcinoma complicated with pulmonary tuberculosis: Case report and review.

IF 1.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Ying Chen, Shu Luo, Quan Zheng, Qing Yu, Chunxia Liu, Rui Tang, Fei Chen, Yan Zhang
{"title":"A case of metachronous triple primary carcinoma complicated with pulmonary tuberculosis: Case report and review.","authors":"Ying Chen, Shu Luo, Quan Zheng, Qing Yu, Chunxia Liu, Rui Tang, Fei Chen, Yan Zhang","doi":"10.1097/MD.0000000000039638","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Multiple primary malignant neoplasms with tuberculosis are rare. The interaction between tuberculosis and tumor remains unclear. Moreover, the treatment of multiple primary tumors combined with tuberculosis is relatively complicated. Herein, we report a case of metachronous triple primary carcinoma complicated with pulmonary tuberculosis.</p><p><strong>Objective: </strong>This report aims to analyze the clinical characteristics of 3 primary tumors combined with tuberculosis. We report the long-term survival of this patient after personalized treatment and this patient have a good quality of life.</p><p><strong>Diagnoses and interventions: </strong>A 55-year-old male patient was diagnosed with squamous cell carcinoma of the lower thoracic esophagus (cT4bN1M0 IVA) and received concurrent chemoradiotherapy, followed by 2 cycles consolidate chemotherapy. During the follow-up, he was diagnosed with secondary tuberculosis (TB) and accepted anti-TB treatment. During anti-TB treatment, he was diagnosed with squamous cell carcinoma of the oropharynx (cT1N0M0 I P16(-)), then he received radical radiation therapy. However, within a year, the patient was diagnosed with oral squamous cell carcinoma (cT3N0M0 IIIA). He accepted an individualized chemotherapy with paclitaxel combined with capecitabine. Moreover, immunohistochemistry of the patient's 3 biopsies indicated positive P53 expression.</p><p><strong>Outcomes: </strong>Since the patient suffered from esophageal cancer, oropharyngeal cancer, and oral floor cancer, no tumor recurrence or metastasis was observed. And he has a good quality of life. Tuberculosis, TP53 mutation, radiotherapy, smoking, and drinking history may be risk factors for multiple primary tumors.</p><p><strong>Lessons: </strong>The treatment of multiple primary tumors combined with pulmonary tuberculosis is complicated. Individualized treatment allows patients to achieve long-term survival while also having a good quality of life. Limitations in this case: surgery may be an alternative strategy for the patient, but the patient refused surgery.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000039638","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Multiple primary malignant neoplasms with tuberculosis are rare. The interaction between tuberculosis and tumor remains unclear. Moreover, the treatment of multiple primary tumors combined with tuberculosis is relatively complicated. Herein, we report a case of metachronous triple primary carcinoma complicated with pulmonary tuberculosis.

Objective: This report aims to analyze the clinical characteristics of 3 primary tumors combined with tuberculosis. We report the long-term survival of this patient after personalized treatment and this patient have a good quality of life.

Diagnoses and interventions: A 55-year-old male patient was diagnosed with squamous cell carcinoma of the lower thoracic esophagus (cT4bN1M0 IVA) and received concurrent chemoradiotherapy, followed by 2 cycles consolidate chemotherapy. During the follow-up, he was diagnosed with secondary tuberculosis (TB) and accepted anti-TB treatment. During anti-TB treatment, he was diagnosed with squamous cell carcinoma of the oropharynx (cT1N0M0 I P16(-)), then he received radical radiation therapy. However, within a year, the patient was diagnosed with oral squamous cell carcinoma (cT3N0M0 IIIA). He accepted an individualized chemotherapy with paclitaxel combined with capecitabine. Moreover, immunohistochemistry of the patient's 3 biopsies indicated positive P53 expression.

Outcomes: Since the patient suffered from esophageal cancer, oropharyngeal cancer, and oral floor cancer, no tumor recurrence or metastasis was observed. And he has a good quality of life. Tuberculosis, TP53 mutation, radiotherapy, smoking, and drinking history may be risk factors for multiple primary tumors.

Lessons: The treatment of multiple primary tumors combined with pulmonary tuberculosis is complicated. Individualized treatment allows patients to achieve long-term survival while also having a good quality of life. Limitations in this case: surgery may be an alternative strategy for the patient, but the patient refused surgery.

一例并发肺结核的三联原发癌:病例报告与综述。
理由合并结核病的多发性原发性恶性肿瘤非常罕见。结核病与肿瘤之间的相互作用仍不明确。此外,多发性原发肿瘤合并肺结核的治疗也相对复杂。在此,我们报告了一例并发肺结核的三联原发癌:本报告旨在分析 3 种原发性肿瘤合并肺结核的临床特点。我们报告了该患者经过个性化治疗后的长期生存情况,该患者的生活质量良好:一名 55 岁的男性患者被诊断为下胸段食管鳞状细胞癌(cT4bN1M0 IVA),并接受了同期放化疗,随后又接受了 2 个周期的巩固化疗。随访期间,他被诊断为继发性肺结核(TB),并接受了抗结核治疗。在抗结核治疗期间,他被诊断为口咽鳞癌(cT1N0M0 I P16(-)),随后接受了根治性放疗。然而,不到一年,患者又被确诊为口腔鳞状细胞癌(cT3N0M0 IIIA)。他接受了紫杉醇联合卡培他滨的个体化化疗。此外,患者 3 例活检的免疫组化结果显示 P53 表达阳性:由于患者曾患食道癌、口咽癌和口腔底癌,因此未发现肿瘤复发或转移。患者生活质量良好。肺结核、TP53 基因突变、放疗、吸烟和饮酒史可能是多发性原发肿瘤的危险因素:多发性原发肿瘤合并肺结核的治疗非常复杂。启示:多发性原发肿瘤合并肺结核的治疗非常复杂,个体化治疗可使患者获得长期生存,同时拥有良好的生活质量。本病例的局限性:手术可能是患者的另一种选择,但患者拒绝手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicine
Medicine 医学-医学:内科
CiteScore
2.80
自引率
0.00%
发文量
4342
审稿时长
>12 weeks
期刊介绍: Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信